Sante Capital Fund’s Veracyte VCYT Stock Holding History

Sante Capital Fund’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-17,274	Closed	-$691K	–	111
2021 Q2	$691K	Buy	+17,274	New	+$739K	0.29%	89

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Sante Capital Fund's VCYT Position: Q3 2021 in Review

Sante Capital Fund sold out of Veracyte (VCYT) in Q3 2021, closing a stake of 17,274 shares — an estimated $691K sold.

Sante Capital Fund first reported a position in VCYT in Q2 2021 and held it in 1 quarter. The position peaked at $691K in Q2 2021. 214 funds tracked by Wall St. Rank hold VCYT as of Q3 2021.

Sante Capital Fund reported no remaining Veracyte position as of Q3 2021 after selling out during the quarter.
Sante Capital Fund sold 17,274 Veracyte shares in Q3 2021, an estimated $691K.
Sante Capital Fund first reported a position in Veracyte in Q2 2021 and held it in 1 quarter.
Sante Capital Fund's Veracyte position peaked at $691K in Q2 2021.
214 funds tracked by Wall St. Rank held Veracyte as of Q3 2021.

Based on Sante Capital Fund's 13F filing for Q3 2021, filed 15 Nov 2021.